US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist
  • 1.064
  • +0.044+4.26%
Trading Mar 4 10:37 ET
23.39MMarket Cap-1.09P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enlivex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Enlivex Therapeutics Earnings Reports

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 29, 2024 16:34 ET

  • Enlivex Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Oct 15, 2024 06:17 ET

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 11, 2024 08:31 ET

  • Enlivex Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 30, 2024 16:34 ET

    • Read more

    Trending Stocks

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    NVIDIA
    NVDA
    111.389
    Tesla
    TSLA
    265.400
    Taiwan Semiconductor
    TSM
    176.030
    4
    Palantir
    PLTR
    80.665
    5
    Advanced Micro Devices
    AMD
    96.360
    Log In for the Full List
    Unlock Now